| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |